These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 32457738)

  • 1. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
    Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
    Front Immunol; 2020; 11():734. PubMed ID: 32457738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cells and inflammation in AKI to CKD progression.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1501-F1512. PubMed ID: 30156114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
    Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
    J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
    Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
    J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular senescence and acute kidney injury.
    Lin X; Jin H; Chai Y; Shou S
    Pediatr Nephrol; 2022 Dec; 37(12):3009-3018. PubMed ID: 35338388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
    Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK
    Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
    Chou YH; Huang TM; Chu TS
    J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
    Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
    Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
    Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease.
    Wang C; Zhang Y; Shen A; Tang T; Li N; Xu C; Liu B; Lv L
    Front Immunol; 2024; 15():1385696. PubMed ID: 38770013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
    Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression.
    Chen J; Lu H; Wang X; Yang J; Luo J; Wang L; Yi X; He Y; Chen K
    FASEB J; 2022 Sep; 36(9):e22472. PubMed ID: 35959877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.